Evaluation of the safety in excess administration of tea beverage containing peptide derived from sardine muscle hydrolyzate on humans

Japanese Pharmacology and Therapeutics

Volumn 33, Issue 11, 2005, Pages 1113-1125

  Kajimoto, Osami ^a   Nakagawa, Satoshi ^b   Kajimoto, Yoshitaka ^b   Takashiba, Masato ^c   Shimano, Kimihide ^c  

^a OSAKA UNIVERSITY   (Japan)

^b Soiken Inc   (Japan)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Excess administration; Hypertension; Hypotensive effects; Safety evaluation; Sardine peptide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEPTIDE; PROTEIN HYDROLYSATE; SARDINE PEPTIDE; UNCLASSIFIED DRUG; VALYLTYROSINE;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BORDERLINE HYPERTENSION; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MALE; PHYSICAL EXAMINATION; SAFETY; SKIN MANIFESTATION; SYSTOLIC BLOOD PRESSURE; TEA; URINALYSIS;

EID: 32844465667     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)